Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-5-9
pubmed:abstractText
B-type natriuretic peptide (BNP) is secreted by overloaded ventricles. Emerging of bedside dosages cause an increasing interest for this peptide as marker in various clinical situations with heart failure. At first, BNP dosage is a potential tool for detecting heart failure and left ventricular dysfunction. BNP has also a powerful and well-established prognosis value in chronic heart failure. In the emergency setting, and mainly about acute dyspnea, low blood BNP level could eliminate diagnosis of congestive heart failure. Moreover, serial measurement of BNP could allow non-invasive hemodynamic monitoring during decompensated heart failure and could also lead cares as need for intensifying treatment. Nevertheless, its daily use in various clinical situations require that cut-off values are refined.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0003-9683
pubmed:author
pubmed:issnType
Print
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
185-8
pubmed:dateRevised
2009-2-13
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Ultra-rapid measurement of brain natriuretic peptide].
pubmed:affiliation
Hôpital Beaujon, Clichy.
pubmed:publicationType
Journal Article, English Abstract, Review